Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
This approval is backed by a decade of proven safety and efficacy data of Ocrevus® IV, with over 350,000 people treated globally
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
Subscribe To Our Newsletter & Stay Updated
